<Insert Picture Here>

APAC - Agile FY10 Q3 Ops Review 30th March ,2010

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 2

Agenda• FY10 Q3 Highlights• FY10 Q4 Highlights

• Q4 Pipe• Q4 Budget and Status• Q4 Top Deals• Marketing Momentum

• Other Highlights

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 3

APAC ANZ ASEAN GC INDIA KOREABudget 632 134 179 214 42 64Actual 580 213 0 345 22 0% Budget 92% 159% 0% 161% 52% 0%

Q1

FY’10 Q2 Performance to Budget

FY10 Budget and Actual

APAC ANZ ASEAN GC INDIA KOREABudget 1001 211 284 339 66 101Actual 420 0 300 85 0 35% Budget 42% 0% 106% 25% 0% 35%

Q2

APAC ANZ ASEAN GC INDIA KOREAFY09 Actual 2,384 21 1,062 1,128 89 - Budget 4,081 862 1,158 1,382 268 411 YTD Actual 1507 213 591 646 22 35

FY’10 Q1 Performance to Budget

FY’10 Q3 Performance to Budget APAC ANZ ASEAN GC INDIA KOREA

Budget 1092 190 255 497 59 91Actual 507 0 291 216 0 0% Budget 46% 0% 114% 43% 0% 0%

Q3

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 4

WINS2 New Customers in Q3 across

APAC

Chartered Semiconductor expanded Footprint to Global Foundries . Standardised their PLM Platform globally on Agile. Next phase of implementation is to replace PTC

Q3 Highlights – Agile

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 5

New Customers Growth Q1- 8Q2 - 5Q3 - 2 15

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 6

FY10 – Q4 Status

• Top Deals in Progress • Foxconn (1064 k) - Closed• Ranbaxy – 200k • Sanitorium – 200 k • Huawei – 600 k

• Small deals to contribute• 600 K from 11 opportunities

APAC ANZ ASEAN GC INDIA KOREAFY09 Actual 2,384 21 1,062 1,128 89 - Budget 4,081 862 1,158 1,382 268 411 YTD Actual 1507 213 591 646 22 35Q4 Budget 1551 328 440 525 102 156

Forecast for Q4 – 2,000 KCurrent Forecast will help us toachieve 86 % of the FY10 budgetand 47 % growth over FY09.

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 7

Region40 %

Uncommitted

40% to 59 %

committed60%+

Committed Total Pipe

APAC 1779 392 1565 3736

Q4 Pipe

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 8

15 Top Active Anchor Deals – Agile Region QTR Account Target Revenue Remarks

ASEAN Q2 CP Foods 300000 CLOSED

ASEAN Q3 Chartered 291000 CLOSED

China Q4 Foxconn 1064000 CLOSED

India Q4 Ranbaxy 170000 Solution Phase

China Q4-Upside Huawei (ULA) 600000 ULA being negotiated

ANZ Q4-Upside Resmed 170000 Still Upside. New CIO giving us tough time

ANZ Q4-Upside Sanitarium 200000 POC engagement being negotiated

ASEAN Q4-Upside IMI 200000 Early Value Assessment done

Korea Q4 Samsung 100000 Pilot project under progress

ANZ FY11 Simplot 250000 Part of Global deal . Commercials

ANZ FY11 Coco Cola Amatil 200000 Early Sales cycle

ASEAN FY11 AVIVA 150000 Orgnaisation going through major restructuring

KOREA FY11 LG Display 500000 POC need to be done again in Q4

India FY11 DRL 200000 Internal approval for the QBD project

China FY11 Beijing Pharmaceuticals 200000 Q4 Upside

Hongkong FY11 Mattel 300000 Global Opportunity APAC POC completed

Taiwan FY11 ASUS 200000

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 9

Targeted 1-1 Workshops – Highlights Named Accounts Pipe Development ASEAN

Panasonic- Completed CP Foods – Won IMI - Completed DEXA Pharmaceuticals - Completed San Miguel – Planned in FY11 AVIVA - Completed

GC Beijing Pharmaceuticals - Completed Mattel - Completed Catcher Technology- completed

Korea Samsung C&T - Completed Doosan Engines and Heavy Engg- Completed Ildong Pharmaceuticals – Completed

ANZ Sanitarium – ANZ- Waiting confirmation

INDIA DRL - Global Workshop for EQM delivered Ranbaxy - Completed and 3 years IT Roadmap being

progressed

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 10

• Manufacturing and PLM Summits in Major cities across APAC• India : Delhi,Mumbai,Chennai• China

Marketing Events – Q3

• APAC• F&B Webcast for Food & Beverages

• ASEAN• Semiconductor Conference in Singapore• PLM series in Supply Chain and Manufacturing Summit

• CHINA• Food & Beverages Technology Innovation Sponsorship – China• Lead maturation events with Partner in 3 cities -China

Marketing Events – Q4

Marketing Momentum

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 11

Other Highlights

CP Foods Implementation – Implementation issue being sorted out and Customer care driving with support from Edge team (Presales) and Development Team supporting Partners for 5 weeks implementation process

Pharmaceuticals Momentum : Ranbaxy – Detailed Discovery session to assess PLM Solution for Generic

Pharma conducted. Potential Q4 though SAP and Siemens in the game. Siemens playing their strength of integrating R&D systems ( with machine interface) directly with PLM

DRL : Global Quality Management workshop to a team of 100 people delivered. High potential account in FY11

Siemens targeting F&B and Pharma aggressively .We need to be cautious and building the right eco system is the critical success factor. Siemens working on building data model for F&B and Pharma

Need to package our GTM – Right GSI , Solution set, Business Case template , Branding , IBU/SC/Sales capability

FY11 plan started and identified potential Target accounts for Agile

CONFIDENTIAL – ORACLE HIGHLY RESTRICTED 12

Q U E S T I O N S

A N S W E R S